Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European orthopaedic and traumatology residency is predominantly integrated, with substantial variability in competency-based models and duty hours: A survey of 33 countries.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2026
Same author

Differential Allergenicity and Heavy Metal Content in Dactylis glomerata and Lolium perenne Pollen Across Contrasting Environments.

Environmental toxicology·2026
Same author

Novel Chewable Pleuran-Based Supplement Decreases Respiratory Tract Infections in Children: A Randomised Controlled Trial.

Advances in therapy·2025
Same author

Discovering Stable Amorphous Ceramics: From Computational Prediction to Thin-Film Synthesis.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

Ion Exchange Synthesizes a Metastable Layered Polymorph of MgZrN<sub>2</sub> and MgHfN<sub>2</sub> Semiconductors.

Chemistry of materials : a publication of the American Chemical Society·2025
Same author

Basin-Size Mapping: Prediction of Metastable Polymorph Synthesizability Across TaC-TaN Alloys.

Journal of the American Chemical Society·2025

Related Experiment Video

Updated: Jul 19, 2026

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

[Ewing sarcoma--current opinion].

Zoran Vukasinović, Vladan Stevanović, Dusko Spasovski

    Srpski Arhiv Za Celokupno Lekarstvo
    |October 3, 2006
    PubMed
    Summary

    Ewing tumor family comprises bone and soft tissue cancers sharing a specific genetic translocation. Treatment involves multimodal chemotherapy, radiation, and surgery, with prognosis depending on tumor location and spread.

    Area of Science:

    • Oncology
    • Genetics
    • Pathology

    Context:

    • The Ewing tumor family includes bone, extraosseous, primitive neurectodermal, and Askin tumors.
    • These tumors share a characteristic reciprocal translocation (11; 22) (q24; q12) and originate from a common stem cell.
    • Ewing tumor is the most prevalent form, representing 60% of cases and is the second most common primary malignant bone tumor.

    Purpose:

    • To outline the characteristics, presentation, and treatment of the Ewing tumor family.
    • To identify prognostic factors influencing patient outcomes.

    Summary:

    • Ewing tumors commonly present with localized lesions (80%) or metastatic disease (20%), often manifesting as pain, swelling, or pathological fractures, particularly in long bones.
    • While extremities are common sites (50%), head/neck localizations are rare; paraspinal or pelvic tumors may cause back pain.

    More Related Videos

    A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
    07:31

    A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

    Published on: May 3, 2021

    Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
    08:07

    Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

    Published on: April 12, 2019

    Related Experiment Videos

    Last Updated: Jul 19, 2026

    Surgical Treatment of an Endolymphatic Sac Tumor
    04:34

    Surgical Treatment of an Endolymphatic Sac Tumor

    Published on: May 26, 2023

    A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
    07:31

    A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

    Published on: May 3, 2021

    Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
    08:07

    Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

    Published on: April 12, 2019

  • Systemic symptoms like fever or weight loss can indicate metastatic disease, frequently involving the lungs, bone, and bone marrow.
  • Impact:

    • Multimodal treatment combining chemotherapy, radiation, and/or surgical resection offers the best therapeutic approach.
    • Favorable prognostic indicators include distal extremity or axial skeleton involvement.
    • Poor prognostic factors encompass proximal tumor sites, pelvic girdle involvement, metastatic disease, and low post-chemotherapy necrosis.